Tim R Mocking

7PUBLICATIONS
21CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Regenerative medicine (incl. stem cells)Medical mycologyRespiratory diseasesMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 07, 2026
CytoScan: Automated Detection of Technical Anomalies for Cytometry Quality Control.

|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.

Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp

|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia.

Tim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos

|Feb 27, 2025
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.

Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog

|Dec 20, 2024
Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models.

Tim R Mocking, Angèle Kelder, Tom Reuvekamp

|Jan 25, 2024
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia.

Jesse M Tettero, Maaike E Heidinga, Tim R Mocking

Pageof 2

Frequent Collaborators

7 joint publications

Costa Bachas

4 joint publications

Lok Lam Ngai

4 joint publications

Arjan A van de Loosdrecht

4 joint publications

Jacqueline Cloos